Reviva’s First Phase III Schizophrenia Readout Rivals Karuna’s Stellar KarXT

Biotech Will Need Cash To Finalize Pivotal Program

 
• By Mandy Jackson
  
Schizophrenia and split personality disorder and mental health psychiatric disease concept
Reviva plans to also develop its drug for bipolar disorder, depression and ADHD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D